IMRX - Immuneering Corporation

-

$undefined

N/A

(N/A)

Immuneering Corporation NASDAQ:IMRX

Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

14.31M

Cash

36.14M

Avg Qtr Burn

-13.75M

Short % of Float

3.92%

Insider Ownership

24.07%

Institutional Own.

12.07%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
IMM-1-104 Details
Solid tumor/s, Cancer, Pancreatic cancer

Phase 2a

Data readout

IMM-1-104 + G12C inhibitor Details
Cancer, Non-small cell lung carcinoma

Phase 2a

Initiation

IMM-1-104 + Libtayo Details
Cancer, Non-small cell lung carcinoma

Phase 2a

Initiation

Phase 2a

Initiation

Phase 2a

Initiation

IMM-6-415 Details
Solid tumor/s

Phase 1/2

Data readout